Form 4 for DCOY Decoy Therapeutics Inc.
Accepted 2022-05-31 00:00:00 ET · period of report 2022-05-31 · accession 0001615219-22-000085 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-05-31 | 2022-05-31 | DCOY | Rosenblum Mark J | CFO, EVP Fin | P - Purchase | $0.18 | +28.0K | 148.3K | +23% | +$5,040 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-05-31 | P | A | 28,000 | $0.18 | 148,319 | D | — | — |